In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Watson buys US rights to 3 Searle contraceptives for $120mm

Executive Summary

Watson Pharmaceuticals (generics, niche drugs) subsidiary Watson Laboratories will acquire US rights to three oral contraceptive products, TriNorinyl, Norinyl and Brevicon from Monsanto subsidiary GD Searle & Co. for $120mm.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies